Immunomedics Inc (IMMU) Return on Assets ROA from the second quarter of 2020 to second quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immunomedics Inc   (NASDAQ: IMMU)


Immunomedics Inc 's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Immunomedics Inc 's ROA in the second quarter of 2020?
Immunomedics Inc recorded a cumulative net loss of $-354 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -51.34%.

However, within the Healthcare sector 568 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2020 quarter, so far to 4195, from total ROA ranking in the first quarter of 2020 at 4414.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Total Assets Change 125.49 % 22.6 % 27.21 % -32.8 % -28.17 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -354 -363 -357 -429 -399
Return On Assets (TTM) -51.34 % -67.37 % -69.87 % -90.28 % -75.92 %
IMMU's Total Ranking # 4195 # 4414 # 4947 # 4569 # 4517
Total Assets (TTM) in million 1,077 594 672 412 478
Seq. Total Assets Change 81.3 % -11.55 % 63.15 % -13.81 % -1.42 %
Seq. Net Income Change - - - - -

IMMU's 5 Years Annual ROA >> Back to IMMU Management Effectiveness >> Compare IMMU ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 569
Overall # 4052

Return On Assets Statistics
High Average Low
-21.82 %
-94 %
-242.61 %
(Sep 30 2013)   (Sep 30 2017)





Financial Statements
Immunomedics Inc 's Assets $ 1,077 million IMMU's Balance sheet
Immunomedics Inc 's Income $ -66 million Quarterly IMMU's Income Statement
IMMU's Income by Division See IMMU's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Jun 30 2018)
FY 2018		 (Jun 30 2017)
FY 2017		 (Jun 30 2016)
FY 2016		 (Jun 30 2015)
FY 2015
Y / Y Total Assets Change 1.14 % 308.54 % 185.47 % -46.16 % 125.81 %
Total Assets in million 672 664 163 57 106
Y / Y Net Income Change - - - - -
Net Income in million -357 -274 -153 -59 -48
Annual Return On Assets -53.19 % -41.24 % -94.28 % -103.84 % -45.49 %

IMMU's 5 Years Annual ROA >> Back to IMMU Management Effectiveness >> Compare IMMU ROA to its Competitors



More Return On Assets Ratios
IMMU's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IMMU's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IMMU's Competitors
Subscribers only: Roa for Immunomedics Inc 's Suppliers
Subscribers only: Return On Assets for IMMU's Customers

You may also want to know
IMMU's Roi IMMU's Inventory Turnover Ratio IMMU's Growth Rates IMMU's Dividend Comparisons
IMMU's Profitability Ratios IMMU's Asset Turnover Ratio IMMU's Dividend Growth
IMMU's Roe IMMU's Valuation Ratios IMMU's Financial Strength Ratios IMMU's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.